Key Statistics for SAZ
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (EUR) (ttm)
|Est. EPS (EUR) (12/2013)
|Est. PEG Ratio
|Market Cap (M EUR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (EUR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SAZ
- Net Income (M/EUR)
Stada Arzneimittel AG manufactures pharmaceuticals. The Company produces generics (products whose patents have expired), brand-name products, and cancer therapy and other special pharmaceuticals. Stada avoids cost-intensive research on active ingredients and concentrates on multi-source products. The Company markets its products worldwide.
More Company Profile & Key Executives for SAZ
|Hartmut RetzlaffChairman-Mgmt Board||Helmut KraftCFO/Member-Mgmt Board|
|Axel MuellerChief Production & Dev Ofcr|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.